Haemonetics | HAE - Sales Revenues

Stock Price
65.61
Daily Change
-1.05 -1.58%
Monthly
-20.10%
Yearly
-0.82%
Q1 Forecast
64.61

Haemonetics reported $327M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Avanos Medical USD 177.8M 2.8M Sep/2025
Baxter International USD 2.84B 30M Sep/2025
Becton, Dickinson and Co. USD 5.9B 400M Sep/2025
Boston Scientific USD 5.07B 10M Sep/2025
Cooper Companies USD 1.07B 4.9M Sep/2025
Fresenius EUR 5.48B 100M Sep/2025
Fresenius Medical Care EUR 4.89B 100M Sep/2025
Globus Medical USD 769M 23.7M Sep/2025
Haemonetics USD 327M 5.61M Sep/2025
Hologic USD 1.05B 0 Dec/2025
ICU Medical USD 537M 11.9M Sep/2025
Intuitive Surgical USD 2.87B 360M Dec/2025
Masimo USD 371.5M 600K Sep/2025
Medtronic USD 8.96B 383M Sep/2025
Merit Medical Systems USD 384.2M 1.7M Sep/2025
Neogen USD 224.69M 15.5M Sep/2025
Quidel USD 700M 86M Sep/2025
ResMed USD 1.4B 100M Dec/2025
STAAR Surgical USD 94.7M 50.4M Sep/2025
Steris USD 1.03B 360M Sep/2025
Stryker USD 7.2B 1.14B Dec/2025
Teleflex USD 913M 132.11M Sep/2025
Terumo JPY 274.97B 15B Sep/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
US Physical Therapy USD 197.13M 210K Sep/2025
Zimmer Biomet Holdings USD 2B 80M Sep/2025